Agenda: State of the Biotech Union

 

Join us at Xconomy's EXOME Presents: State of the Biotech Union on December 6
 AGENDA
 .
12:30 – 1:30 Registration & Networking
1:30 – 1:40 Welcome & Introduction
Jim Edwards, Publisher, Xconomy
Alex Lash, Xconomy
Aarif Khakoo, VP Research and San Francisco Site Head, Amgen
1:40 – 2:10 The Promise and Reality of Gene Editing
Jacob Corn, Scientific Director, Innovative Genomics Initiative, UC Berkeley
Matthew Porteus, Associate Professor of Pediatrics, Stanford University
Marcy Darnovsky, Executive Director, Center for Genomics and Society (Moderator)
2:10 – 2:40 Biotech In The Network Era
John Wilbanks, Chief Commons Officer, Sage Bionetworks
2:40 – 3:10 Software Eats Bio
Vijay Pande, General Partner, Andreessen Horowitz
Alex Lash, Xconomy
3:10 – 3:25 Wilbanks & Pande Answer Your Questions
Vijay Pande, General Partner, Andreessen Horowitz
John Wilbanks, Chief Commons Officer, Sage Bionetworks
3:25 – 3:55 Networking Break
3:55 – 4:20 Tackling Zika And Other Infectious Threats
Nima Farzan, CEO, PaxVax
Melanie Ott, Senior Investigator, Gladstone Institute of Virology and Immunology, UCSF
Duncan MacCannell, CSO, OAMD, Centers for Disease Control and Prevention
Alex Lash, Xconomy (Moderator)
4:20 – 4:45 The Future Of The Cancer Moonshot
Peter Kuhn, Dean’s Professor of Biological Sciences; Professor of Medicine and Engineering, USC
4:45 – 5:15 Biotech In Trumpland: What Comes Next
Laurent Fischer, CEO, Tobira Therapeutics
Camille Samuels, Partner, Venrock
Adams Dudley, Director, UCSF Center for Healthcare Value
Jenny Rooke, Managing Director, 5 Prime Ventures
Alex Lash, Xconomy (Moderator)
5:15 – 6:30 Networking Reception



*Schedule is subject to change.

Register here.